Return to Heparin homepage on SSEM.COM
Baxter faced a similar problem in the 1990s. In 1994, the CDC began seeing a spike in reports of hepatitis C for people who were receiving intravenous immune globulin, a plasma derivative. None of the other producers of immune globulin had their products called into question because they had virally inactivated their product before putting it on the market. Eventually, the CDC determined that all of the hepatitis C cases associated with intravenous immune globulin came from Baxter's Gammagard®, which Baxter had not virally inactivated.
"We believe that Baxter cut corners with Gammagard® by not virally inactivating before they sold it and are investigating whether the same thing occurred with Heparin," said John Evans, a Specter attorney and lead counsel in the Gammagard® litigation.
The attorneys at Specter Specter Evans & Manogue, P.C. have more than 50 years' combined experience in litigating against big drug companies. Along with a handful of other law firms, the Specter firm took on Baxter for injuries people suffered from having been infused with Baxter's Gammagard®.
Specter Specter Evans & Manogue, P.C. served as lead class counsel in Geary v. Baxter Healthcare, a nationwide class action that provided testing to everyone who received Gammagard® to determine if they had hepatitis C and gained financial compensation for those who contracted hepatitis C from Baxter's Gammagard®. The firm also led the way for people to get compensation after having suffered from Stevens Johnson Syndrome from prescription and over-the-counter medication, heart attacks from Vioxx® and rhabdomyolysis from Baycol®, to name just a few.
What should you do? First, if you or a family member has been given Heparin since September 2007 and experienced any unusual side effects, contact your doctor's office or hospital to find out if you received Baxter's Heparin. If you received Heparin and experienced any side effects, you should also contact John Evans or Megan Faust at Specter Specter Evans & Manogue, P.C. by using the form below.
Copyright © 1999-2008 Specter Specter Evans & Manogue, P.C.
Terms of Use | Privacy Policy